| Publication | Date of Publication | Type |
|---|
Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkers
Statistics in Medicine | 2025-11-10 | Paper |
Linear mixed-effects models for central statistical monitoring of multicenter clinical trials
Statistics in Medicine | 2025-11-06 | Paper |
Professor Maurice Staquet, MD, MS (1930--2013)
Statistics in Medicine | 2025-08-08 | Paper |
Individualized net benefit estimation and meta-analysis using generalized pairwise comparisons in \(N\)-of-1 trials
Statistics in Medicine | 2024-10-30 | Paper |
Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: a simulation study
Statistics in Medicine | 2024-10-29 | Paper |
Minimization in randomized clinical trials
Statistics in Medicine | 2024-06-23 | Paper |
Generalized pairwise comparisons for censored data: an overview
Biometrical Journal | 2024-06-05 | Paper |
Correcting the bias of the net benefit estimator due to right‐censored observations
Biometrical Journal | 2023-11-27 | Paper |
A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons
Biometrical Journal | 2023-11-23 | Paper |
Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes
Biometrical Journal | 2020-09-22 | Paper |
Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials
Computational Statistics and Data Analysis | 2018-08-14 | Paper |
An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference
Biometrics | 2016-10-12 | Paper |
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
Biometrical Journal | 2016-03-14 | Paper |
On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints
Biometrics | 2016-01-22 | Paper |
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time
Biometrics | 2012-06-27 | Paper |
Exploring and validating surrogate endpoints in colorectal cancer
Lifetime Data Analysis | 2009-07-13 | Paper |
The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
Journal of Statistical Planning and Inference | 2008-03-11 | Paper |
A perspective on surrogate endpoints in controlled clinical trials
Statistical Methods in Medical Research | 2007-11-05 | Paper |
Validation of a longitudinally measured surrogate marker for a time-to-event endpoint
Journal of Applied Statistics | 2007-09-11 | Paper |
Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints
Biometrics | 2007-06-11 | Paper |
Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
Journal of the Royal Statistical Society Series C: Applied Statistics | 2007-05-30 | Paper |
Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
Biometrics | 2005-04-11 | Paper |
Simplified hierarchical linear models for the evaluation of surrogate endpoints
Journal of Statistical Computation and Simulation | 2003-10-29 | Paper |
Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
Journal of the Royal Statistical Society Series C: Applied Statistics | 2001-12-01 | Paper |
The validation of surrogate endpoints in meta-analyses of randomized experiments
Biostatistics | 2000-07-11 | Paper |
| scientific article; zbMATH DE number 3911553 (Why is no real title available?) | 1983-01-01 | Paper |
